医药化学优化的不断变化的格局
Anita Rácz1, Levente M Mihalovits1,2, Maximilian Beckers3,4
1National Drug Research and Development Laboratory, Drug Innovation Centre, Research Centre for Natural Sciences, Budapest, Hungary.
Nature reviews. Drug discovery
|July 7, 2025
概括
药物化学的优化已经进化,与早期相比,现代候选药物显示出更好的分子特性. 这项研究分析了物理化学性质的趋势和药物发现计划的战略转变.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 制药科学 制药科学
背景情况:
- 小分子药物发现旨在开发用于临床试验的化学实体.
- 这涉及到分子性质的代优化,从击中到导致候选药物阶段.
- 评估随着时间的推移的属性变化,揭示了药用化学策略的趋势.
研究的目的:
- 分析药物化学优化对候选药物的分子性质的影响.
- 将最近文献 (2015-2022) 中的候选药物及其前体与早期 (2000-2010年) 的前体进行比较.
- 检查AstraZeneca和Novartis的内部药物发现计划,以寻找类似的趋势.
主要方法:
- 打击,和药物候选化合物的物理化学性质的比较分析.
- 关于候选药物及其在2000-2010年和2015-2022年间的发展阶段的文献综述.
- 分析来自AstraZeneca和Novartis的内部药物化学计划数据.
主要成果:
- 随着时间的推移,观察到候选药物的关键物理化学性质的变化.
- 在药用化学计划中确定了影响优化途径的战略变化.
- 最近的候选药物与较旧的药物相比,具有不同的分子特性.
结论:
- 药物化学优化策略已经发展,影响候选药物的特性.
- 了解这些趋势对于指导未来药物发现工作至关重要.
- 这项研究强调了过去二十年中成功的候选药物的分子特征的显著变化.
相关概念视频
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
269
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
269
Drug Administration and Therapy Phases: Overview
766
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
766
Drug Biotransformation: Overview
2.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.9K
Drug Clearance: Overview
168
Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
168


